ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $840.04M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 663
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DTI | 2026-09-24 16:31 | 2026-09-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-24 16:31 | 2026-09-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $491.57 | -9,500 | 324.4K | -3% | -$4.67M |
| DTI | 2026-09-23 16:30 | 2026-09-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-23 16:30 | 2026-09-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $494.83 | -9,500 | 324.4K | -3% | -$4.70M |
| DTI | 2026-09-22 16:33 | 2026-09-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-22 16:33 | 2026-09-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $494.55 | -9,500 | 324.4K | -3% | -$4.70M |
| DTI | 2026-09-21 16:44 | 2026-09-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-21 16:44 | 2026-09-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $494.79 | -9,500 | 324.4K | -3% | -$4.70M |
| DTI | 2026-09-18 16:41 | 2026-09-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-18 16:41 | 2026-09-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $496.06 | -9,500 | 324.4K | -3% | -$4.71M |
| DTI | 2026-09-17 16:43 | 2026-09-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-17 16:43 | 2026-09-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $501.39 | -9,500 | 324.4K | -3% | -$4.76M |
| DTI | 2026-09-16 16:35 | 2026-09-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-16 16:35 | 2026-09-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $501.59 | -9,500 | 324.4K | -3% | -$4.77M |
| DTI | 2026-09-15 16:34 | 2026-09-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-15 16:34 | 2026-09-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $504.12 | -9,500 | 324.4K | -3% | -$4.79M |
| DTI | 2026-09-14 16:43 | 2026-09-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-14 16:43 | 2026-09-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $500.82 | -9,500 | 324.4K | -3% | -$4.76M |
| DTI | 2026-09-11 16:34 | 2026-09-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-11 16:34 | 2026-09-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $502.35 | -9,500 | 324.4K | -3% | -$4.77M |
| DTI | 2026-09-10 16:31 | 2026-09-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-10 16:31 | 2026-09-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $501.84 | -9,500 | 324.4K | -3% | -$4.77M |
| DTI | 2026-09-09 16:33 | 2026-09-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-09 16:33 | 2026-09-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $499.03 | -9,500 | 324.4K | -3% | -$4.74M |
| DTI | 2026-09-08 16:31 | 2026-09-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $117.76 | +9,500 | 333.9K | +3% | +$1.12M |
| DMTI | 2026-09-08 16:31 | 2026-09-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $489.20 | -9,500 | 324.4K | -3% | -$4.65M |
| DMTI | 2026-09-04 16:31 | 2026-09-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $134.32 | +9,500 | 333.9K | +3% | +$1.28M |
| DMTI | 2026-09-04 16:31 | 2026-09-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $487.54 | -9,500 | 324.4K | -3% | -$4.63M |
| DTI | 2026-09-03 16:31 | 2026-09-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-09-03 16:31 | 2026-09-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $493.46 | -9,500 | 324.4K | -3% | -$4.69M |
| DTI | 2026-09-02 16:34 | 2026-09-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-09-02 16:34 | 2026-09-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $514.09 | -9,500 | 324.4K | -3% | -$4.88M |
| DTI | 2026-09-01 16:33 | 2026-08-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-09-01 16:33 | 2026-08-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $511.09 | -9,500 | 324.4K | -3% | -$4.86M |
| DTI | 2026-08-31 16:34 | 2026-08-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-31 16:34 | 2026-08-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $517.51 | -9,500 | 324.4K | -3% | -$4.92M |
| DTI | 2026-08-28 16:30 | 2026-08-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-28 16:30 | 2026-08-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $522.57 | -9,500 | 324.4K | -3% | -$4.96M |
| DTI | 2026-08-27 16:34 | 2026-08-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-27 16:34 | 2026-08-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $517.28 | -9,500 | 324.4K | -3% | -$4.91M |
| DTI | 2026-08-26 16:30 | 2026-08-25 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-26 16:30 | 2026-08-25 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $517.71 | -9,500 | 324.4K | -3% | -$4.92M |
| DTI | 2026-08-25 16:38 | 2026-08-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-25 16:38 | 2026-08-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $511.97 | -9,500 | 324.4K | -3% | -$4.86M |
| DTI | 2026-08-24 16:30 | 2026-08-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-24 16:30 | 2026-08-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $518.39 | -9,500 | 324.4K | -3% | -$4.92M |
| DTI | 2026-08-21 16:44 | 2026-08-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-21 16:44 | 2026-08-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $521.02 | -9,500 | 324.4K | -3% | -$4.95M |
| DTI | 2026-08-20 16:37 | 2026-08-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-20 16:37 | 2026-08-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $526.96 | -9,500 | 324.4K | -3% | -$5.01M |
| DTI | 2026-08-19 16:33 | 2026-08-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-19 16:33 | 2026-08-18 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $515.60 | -9,500 | 324.4K | -3% | -$4.90M |
| DTI | 2026-08-18 16:31 | 2026-08-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-18 16:31 | 2026-08-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $506.59 | -9,500 | 324.4K | -3% | -$4.81M |
| DTI | 2026-08-17 16:34 | 2026-08-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-17 16:34 | 2026-08-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $498.91 | -9,500 | 324.4K | -3% | -$4.74M |
| DTI | 2026-08-14 16:41 | 2026-08-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-14 16:41 | 2026-08-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $504.24 | -9,500 | 324.4K | -3% | -$4.79M |
| DTI | 2026-08-13 17:09 | 2026-08-12 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-13 17:09 | 2026-08-12 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $515.03 | -9,500 | 324.4K | -3% | -$4.89M |
| DTI | 2026-08-12 16:30 | 2026-08-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-12 16:30 | 2026-08-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $522.87 | -9,500 | 324.4K | -3% | -$4.97M |
| DTI | 2026-08-11 16:30 | 2026-08-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-11 16:30 | 2026-08-10 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $530.11 | -9,500 | 324.4K | -3% | -$5.04M |
| DTI | 2026-08-10 16:38 | 2026-08-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-10 16:38 | 2026-08-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $531.38 | -9,500 | 324.4K | -3% | -$5.05M |
| DTI | 2026-08-07 16:30 | 2026-08-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-07 16:30 | 2026-08-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $525.36 | -9,500 | 324.4K | -3% | -$4.99M |
| DTI | 2026-08-06 16:34 | 2026-08-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-06 16:34 | 2026-08-05 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $518.74 | -9,500 | 324.4K | -3% | -$4.93M |
| DTI | 2026-08-05 16:36 | 2026-08-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-05 16:36 | 2026-08-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $517.09 | -9,500 | 324.4K | -3% | -$4.91M |
| DTI | 2026-08-04 16:32 | 2026-08-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-04 16:32 | 2026-08-03 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $516.06 | -9,500 | 324.4K | -3% | -$4.90M |
| DTI | 2026-08-03 16:32 | 2026-07-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-08-03 16:32 | 2026-07-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $518.96 | -9,500 | 324.4K | -3% | -$4.93M |
| DTI | 2026-07-31 16:18 | 2026-07-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-31 16:18 | 2026-07-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $524.90 | -9,500 | 324.4K | -3% | -$4.99M |
| DTI | 2026-07-30 07:58 | 2026-07-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-30 07:58 | 2026-07-29 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $522.37 | -9,500 | 324.4K | -3% | -$4.96M |
| DTI | 2026-07-28 18:19 | 2026-07-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-28 18:19 | 2026-07-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $526.73 | -9,500 | 324.4K | -3% | -$5.00M |
| DTI | 2026-07-27 21:36 | 2026-07-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-27 21:36 | 2026-07-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $530.42 | -9,500 | 324.4K | -3% | -$5.04M |
| DTI | 2026-07-27 06:55 | 2026-07-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-27 06:55 | 2026-07-24 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $531.74 | -9,500 | 324.4K | -3% | -$5.05M |
| DTI | 2026-07-24 16:30 | 2026-07-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-24 16:30 | 2026-07-23 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $528.58 | -9,500 | 324.4K | -3% | -$5.02M |
| DTI | 2026-07-23 16:36 | 2026-07-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-23 16:36 | 2026-07-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $530.57 | -9,500 | 324.4K | -3% | -$5.04M |
| DTI | 2026-07-22 16:30 | 2026-07-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-22 16:30 | 2026-07-21 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $532.24 | -9,500 | 324.4K | -3% | -$5.06M |
| DTI | 2026-07-21 16:35 | 2026-07-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-21 16:35 | 2026-07-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $531.69 | -9,500 | 324.4K | -3% | -$5.05M |
| DTI | 2026-07-20 16:32 | 2026-07-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-20 16:32 | 2026-07-17 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $537.05 | -9,500 | 324.4K | -3% | -$5.10M |
| DTI | 2026-07-17 16:30 | 2026-07-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +9,500 | 333.9K | +3% | +$1.29M |
| DMTI | 2026-07-17 16:30 | 2026-07-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $530.91 | -9,500 | 324.4K | -3% | -$5.04M |
| DT | 2026-07-16 16:30 | 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $135.42 | +1,718 | 42.2K | +4% | +$232.7K |
| DMT | 2026-07-16 16:30 | 2026-07-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $530.41 | -1,718 | 40.5K | -4% | -$911.3K |
Purchase Sale Sale after option exercise All abbreviations